Yang, Kaghad, Wang et al.: "p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities." in: Molecular cell, Vol. 2, Issue 3, pp. 305-16, 1998 (PubMed).
Celli J, Duijf P, Hamel BC et al.: "Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome." in: Cell, Vol. 99, Issue 2, pp. 143-53, 1999 (PubMed).
Signoretti, Waltregny, Dilks et al.: "p63 is a prostate basal cell marker and is required for prostate development." in: The American journal of pathology, Vol. 157, Issue 6, pp. 1769-75, 2000 (PubMed).
Pelosi G, Pasini F, Olsen Stenholm C et al.: "p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?" in: J Pathol, Vol. 198, Issue 1, pp. 100-9, 2002 (PubMed).